A Randomized, Open-label, Multiple Dose, Two-part Phase I Clinical Trial to Compare the Pharmacokinetics, Pharmacodynamics and Safety/Tolerability of DWP14012 After Administrations of DWP14012 Alone and Combinations of DWP14012, Clarithromycin and Amoxicillin in Healthy Male Subjects
Phase of Trial: Phase I
Latest Information Update: 27 Jun 2019
Price : $35 *
At a glance
- Drugs Amoxicillin (Primary) ; Clarithromycin (Primary) ; DWP 14012 (Primary) ; Lansoprazole
- Indications Gastro-oesophageal reflux
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Daewoong Pharmaceutical
- 25 Jun 2019 Status changed from recruiting to completed.
- 20 Jun 2018 Status changed from not yet recruiting to recruiting.
- 06 Apr 2018 New trial record